1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CATALYST PHARMACEUTICALS INC
Catalyst Pharmaceuticals Inc XNAS: CPRX

Catalyst Pharma Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer
about

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAP...

Read More
24.35 -0.10 (-0.41%)
27.82% Gain from 52W Low
712.9K
XNAS Volume

XNAS 26 Dec, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Affordable Valuation
50.3 / 100
Momentum Score
Technically Moderately Bullish
63.3 / 100
Strong Performer These stock companies have strong financials and are affordably priced. They also score high in quality and technical metrics which make them popular with investors View Similar Embed DVM
Analyst Price Target
35
1Yr Price target upside is 43%
7 analysts

23

S

5

W

6

O

0

T

SWOT Analysis

Catalyst Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..